Quest Diagnostics (DGX) Acquisitions (2009 - 2026)

Quest Diagnostics has disclosed Acquisitions across 17 years of filings, most recently posting $38.0 million for Q1 2026.

• Acquisitions for Q1 2026 came in at $38.0 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $139.0 million (down 77.97% YoY), and the FY2025 annual result was $101.0 million, down 95.33% from the prior year.
• Acquisitions came in at $38.0 million for Q1 2026 at Quest Diagnostics, down from $50.0 million in the prior quarter.
• In the past five years, Acquisitions ranged from a high of $578.0 million in Q2 2023 to a low of $1.0 million in Q2 2022.
• The 5-year median for Acquisitions is $44.0 million (2022), against an average of $130.4 million.
• Across the five-year window, Acquisitions tumbled 99.57% in 2022 and soared 57700.0% in 2023, its largest moves.
• Quest Diagnostics' Acquisitions stood at $38.0 million in 2022, then tumbled by 94.74% to $2.0 million in 2023, then surged by 19050.0% to $383.0 million in 2024, then plunged by 86.95% to $50.0 million in 2025, then decreased by 24.0% to $38.0 million in 2026.
• The last three Acquisitions figures came in at $38.0 million (Q1 2026), $50.0 million (Q4 2025), and $34.0 million (Q3 2025), per Business Quant data.